amantadine has been researched along with Nausea in 21 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amantadine was reported to decrease serum alanine aminotransferase and HCV RNA levels in chronic hepatitis C patients who had not respond to interferon, but further experience has produced mixed results." | 9.09 | Treatment of chronic hepatitis C patients with amantadine. ( Harada, H; Yagura, M, 2001) |
| "Amantadine was reported to decrease serum alanine aminotransferase and HCV RNA levels in chronic hepatitis C patients who had not respond to interferon, but further experience has produced mixed results." | 5.09 | Treatment of chronic hepatitis C patients with amantadine. ( Harada, H; Yagura, M, 2001) |
| "Amantadine was first reported effective in the treatment of Parkinson's disease in 1969 and several studies were published in the 1970s supporting its efficacy." | 2.72 | Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease? ( Feldman, M; Margolesky, J; Marmol, S; Singer, C, 2021) |
| "Bromocriptine appears to be an interesting development in the treatment of Parkinson's disease." | 2.64 | [Treatment of parkinsonian syndromes by bromocriptin]. ( Durand, JP; Gautier, JC, 1977) |
| "Ophthalmologists must be aware that SSPE can knock their door with ocular findings of SSPE, months or years before the onset of neurological symptoms." | 2.48 | Neuro-ophthalmology of subacute sclerosing panencephalitis: two cases and a review of the literature. ( Anlar, B; Colpak, AI; Erdener, SE; Kansu, T; Ozgen, B, 2012) |
| "Amantadine was added to the existing regimens in weekly increments to 400 mg/day." | 1.28 | Amantadine hydrochloride for refractory generalized epilepsy in adults. ( Denio, LS; Drake, ME; Pakalnis, A; Phillips, B, 1991) |
| "The drug treatment of Parkinson's disease should be tailored to the age of the patient, coexistence of dementia or postural hypotension, duration of the disease process and the emergence of side effects." | 1.27 | The drug treatment of Parkinson's disease. ( Morris, JG, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (80.95) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Marmol, S | 1 |
| Feldman, M | 1 |
| Singer, C | 1 |
| Margolesky, J | 1 |
| Colpak, AI | 1 |
| Erdener, SE | 1 |
| Ozgen, B | 1 |
| Anlar, B | 1 |
| Kansu, T | 1 |
| Morris, JG | 2 |
| Yagura, M | 1 |
| Harada, H | 1 |
| Gautier, JC | 1 |
| Durand, JP | 1 |
| Drake, ME | 1 |
| Pakalnis, A | 1 |
| Denio, LS | 1 |
| Phillips, B | 1 |
| Godwin-Austen, RB | 1 |
| Frears, CC | 1 |
| Bergmann, S | 1 |
| Parkes, JD | 2 |
| Knill-Jones, RP | 2 |
| Campbell, AM | 1 |
| Williams, MJ | 1 |
| Rinne, UK | 1 |
| Appleton, DB | 1 |
| Eadie, MJ | 1 |
| Sutherland, JM | 1 |
| Gilligan, BS | 1 |
| Veale, J | 1 |
| Wodak, J | 1 |
| Zilkha, KJ | 1 |
| Clements, PJ | 1 |
| Baxter, R | 1 |
| Critchley, E | 1 |
| Reveno, WS | 1 |
| Bauer, RB | 1 |
| Rosenbaum, H | 1 |
| Birkmayer, W | 1 |
| Schwieger, AC | 1 |
| Jenkins, AC | 1 |
5 reviews available for amantadine and Nausea
| Article | Year |
|---|---|
Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease?
Topics: Amantadine; Animals; Antiparkinson Agents; Confusion; Delayed-Action Preparations; Dopamine; Drug Th | 2021 |
Neuro-ophthalmology of subacute sclerosing panencephalitis: two cases and a review of the literature.
Topics: Adolescent; Amantadine; Antibodies, Viral; Anticonvulsants; Antiviral Agents; Blindness; Carbamazepi | 2012 |
The management of Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; H | 1982 |
Recent advances in the treatment of Parkinsonism with drugs.
Topics: Amantadine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Blood-Brain | 1972 |
Use of drugs in the treatment of parkinsonism.
Topics: Amantadine; Depression; Dihydroxyphenylalanine; Feeding and Eating Disorders; Humans; Hypertension; | 1970 |
7 trials available for amantadine and Nausea
| Article | Year |
|---|---|
Treatment of chronic hepatitis C patients with amantadine.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Amantadine; Antiviral Agents; Cataract; Cognit | 2001 |
[Treatment of parkinsonian syndromes by bromocriptin].
Topics: Aged; Amantadine; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Human | 1977 |
Combined treatment of parkinsonism with L-dopa and amantadine.
Topics: Aged; Amantadine; Chorea; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Humans; Hypotens | 1970 |
Trial of amantadine in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Clinical Trials as Topic; Constipation; Female; Hallucinations; Handwriting | 1972 |
Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
Topics: Activities of Daily Living; Adult; Aged; Amantadine; Analysis of Variance; Clinical Trials as Topic; | 1970 |
Amantadine hydrochloride in the treatment of Parkinson's disease.
Topics: Adult; Aged; Amantadine; Clinical Trials as Topic; Female; Headache; Humans; Male; Middle Aged; Naus | 1970 |
L-dopa and amantadine hydrochloride in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Disability Evaluation; Fe | 1971 |
9 other studies available for amantadine and Nausea
| Article | Year |
|---|---|
The drug treatment of Parkinson's disease.
Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Com | 1984 |
Amantadine hydrochloride for refractory generalized epilepsy in adults.
Topics: Adolescent; Adult; Amantadine; Anticonvulsants; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, | 1991 |
Levodopa and related drugs.
Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders; | 1973 |
Levodopa and amantadine in the treatment of Parkinsonism.
Topics: Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Movement Disorders; Nau | 1972 |
L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Topics: Aged; Amantadine; Chlorides; Depression; Dihydroxyphenylalanine; Drug Hypersensitivity; Female; Foll | 1971 |
[Conservative therapy in the Parkinson syndrome].
Topics: Amantadine; Antidepressive Agents; Dihydroxyphenylalanine; Humans; Imipramine; Injections, Intraveno | 1971 |
A second report on Levodopa.
Topics: Amantadine; Arrhythmias, Cardiac; Cerebrovascular Disorders; Dihydroxyphenylalanine; Humans; Hypoten | 1969 |
Specific therapy in Parkinson's disease.
Topics: Amantadine; Dihydroxyphenylalanine; Humans; Hypotension, Orthostatic; Nausea; Parkinson Disease; Vom | 1970 |
Observations on the effect of amantadine hydrochloride in the treatment of Parkinsonism.
Topics: Aged; Amantadine; Depression; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Muscle Tonu | 1970 |